Financhill
Sell
36

CDLX Quote, Financials, Valuation and Earnings

Last price:
$1.61
Seasonality move :
20.37%
Day range:
$1.70 - $1.84
52-week range:
$1.22 - $9.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.32x
P/B ratio:
1.40x
Volume:
460.7K
Avg. volume:
868.7K
1-year change:
-81.45%
Market cap:
$89.8M
Revenue:
$278.3M
EPS (TTM):
-$3.56

Analysts' Opinion

  • Consensus Rating
    Cardlytics has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $2.54, Cardlytics has an estimated upside of 48.54% from its current price of $1.71.
  • Price Target Downside
    According to analysts, the lowest downside price target is $2.00 representing 100% downside risk from its current price of $1.71.

Fair Value

  • According to the consensus of 5 analysts, Cardlytics has 48.54% upside to fair value with a price target of $2.54 per share.

CDLX vs. S&P 500

  • Over the past 5 trading days, Cardlytics has underperformed the S&P 500 by -3.19% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Cardlytics does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cardlytics revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Cardlytics reported revenues of $61.9M.

Earnings Growth

  • Cardlytics has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Cardlytics reported earnings per share of -$0.26.
Enterprise value:
251.7M
EV / Invested capital:
0.91x
Price / LTM sales:
0.32x
EV / EBIT:
--
EV / Revenue:
0.92x
PEG ratio (5yr expected):
-0.09x
EV / Free cash flow:
-15.19x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$115.2M
Return On Assets:
-39.37%
Net Income Margin (TTM):
-65.41%
Return On Equity:
-145.45%
Return On Invested Capital:
-51.7%
Operating Margin:
-31.29%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $294.9M $312.5M $272.6M $67.6M $61.9M
Gross Profit $110.9M $136.7M $115.2M $30.9M $25.2M
Operating Income -$122.2M -$60M -$65.9M -$17M -$19.4M
EBITDA -$442.7M -$137.3M -$140.8M -$15.7M -$4M
Diluted EPS -$14.48 -$4.60 -$3.56 -$0.56 -$0.26
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $702.6M $319.4M $246.4M $218.3M $156.8M
Total Assets $1B $1.2B $684.6M $569M $369.1M
Current Liabilities $92M $246.8M $190.8M $102.6M $131.9M
Total Liabilities $278.1M $519.5M $452.3M $369.8M $305M
Total Equity $744.9M $711.7M $232.3M $199.1M $64.1M
Total Debt $176.5M $224.9M $256.4M $257.9M $213.9M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations -$44.3M -$7.7M $2.1M -$17.6M -$6.7M
Cash From Investing -$13.5M -$12M -$17.9M -$4.7M -$3.9M
Cash From Financing -$10.2M -$21.7M -$29.9M $28.3M -$3M
Free Cash Flow -$57.8M -$22.1M -$16.6M -$22.4M -$10.8M
CDLX
Sector
Market Cap
$89.8M
$87.7M
Price % of 52-Week High
17.49%
68.66%
Dividend Yield
0%
0%
Shareholder Yield
9.16%
3.71%
1-Year Price Total Return
-81.45%
-7.73%
Beta (5-Year)
1.248
0.583
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $1.75
200-day SMA
Sell
Level $3.00
Bollinger Bands (100)
Sell
Level 1.58 - 2.96
Chaikin Money Flow
Buy
Level 21.8M
20-day SMA
Sell
Level $1.85
Relative Strength Index (RSI14)
Sell
Level 43.57
ADX Line
Sell
Level 13.97
Williams %R
Buy
Level -80.7018
50-day SMA
Sell
Level $1.73
MACD (12, 26)
Sell
Level -0.03
25-day Aroon Oscillator
Sell
Level -76
On Balance Volume
Neutral
Level 57.7M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-5.0015)
Sell
CA Score (Annual)
Level (-3.2448)
Buy
Beneish M-Score (Annual)
Level (-4.8631)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (4.6348)
Buy
Piotroski F Score (Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Stock Forecast FAQ

In the current month, CDLX has received 0 Buy ratings 5 Hold ratings, and 0 Sell ratings. The CDLX average analyst price target in the past 3 months is $2.54.

  • Where Will Cardlytics Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cardlytics share price will rise to $2.54 per share over the next 12 months.

  • What Do Analysts Say About Cardlytics?

    Analysts are divided on their view about Cardlytics share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cardlytics is a Sell and believe this share price will drop from its current level to $2.00.

  • What Is Cardlytics's Price Target?

    The price target for Cardlytics over the next 1-year time period is forecast to be $2.54 according to 5 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.

  • Is CDLX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cardlytics is a Hold. 5 of 5 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of CDLX?

    You can purchase shares of Cardlytics via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cardlytics shares.

  • What Is The Cardlytics Share Price Today?

    Cardlytics was last trading at $1.61 per share. This represents the most recent stock quote for Cardlytics. Yesterday, Cardlytics closed at $1.71 per share.

  • How To Buy Cardlytics Stock Online?

    In order to purchase Cardlytics stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is MSTR Stock Fundamentally Misunderstood?
Is MSTR Stock Fundamentally Misunderstood?

Software firm turned Bitcoin treasury Strategy (NASDAQ:MSTR) has made waves…

Is Alphabet or Amazon the Better Buy?
Is Alphabet or Amazon the Better Buy?

Alphabet (NASDAQ:GOOG) and Amazon (NASDAQ:AMZN) are two of the mega-cap…

Why Did Ken Griffin Buy Sweetgreen Stock?
Why Did Ken Griffin Buy Sweetgreen Stock?

In Q1, Ken Griffin’s Citadel Advisors purchased nearly 1.3 million…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
73
OKLO alert for Jun 12

Oklo [OKLO] is down 5.6% over the past day.

Buy
87
SMR alert for Jun 12

NuScale Power [SMR] is down 2.96% over the past day.

Buy
53
PLAY alert for Jun 12

Dave & Buster's Entertainment [PLAY] is up 0.69% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock